112 related articles for article (PubMed ID: 28260213)
1. Chemotherapy-related acute respiratory distress syndrome in germ cell tumors: a literature review.
Alsharedi M; Elmsherghi N; Haydock MM; Bukamur H
Med Oncol; 2017 Apr; 34(4):56. PubMed ID: 28260213
[TBL] [Abstract][Full Text] [Related]
2. First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs).
Pliarchopoulou K; Pectasides D
Cancer Treat Rev; 2009 Nov; 35(7):563-9. PubMed ID: 19576697
[TBL] [Abstract][Full Text] [Related]
3. Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies.
Beer TM; Tangen CM; Nichols CR; Margolin KA; Dreicer R; Stephenson WT; Quinn DI; Raghavan D; Crawford ED
Cancer; 2006 Jun; 106(12):2624-9. PubMed ID: 16688776
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-based chemotherapy for pulmonary metastasized germ cell tumors of the testis--be aware of acute respiratory distress syndrome.
Boeck S; Metzeler KH; Hausmann A; Baumann A; Gallmeier E; Parhofer KG; Stemmler HJ
Onkologie; 2009 Mar; 32(3):125-8. PubMed ID: 19295253
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase II alpha expression in testicular germ cell tumors.
Dimov ND; Zynger DL; Luan C; Kozlowski JM; Yang XJ
Urology; 2007 May; 69(5):955-61. PubMed ID: 17482942
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
Mandoky L; Szende B; Géczi L; Bodrogi I; Kásler M; Bak M
Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of male seminomatous and nonseminomatous germ cell tumors and response to first-line chemotherapy from a tertiary cancer center in India.
Joshi A; Zanwar S; Shetty N; Patil V; Noronha V; Bakshi G; Prakash G; Menon S; Prabhash K
Indian J Cancer; 2016; 53(2):313-316. PubMed ID: 28071636
[TBL] [Abstract][Full Text] [Related]
9. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
10. Emerging Therapeutic Targets for Male Germ Cell Tumors.
Fankhauser CD; Honecker F; Beyer J; Bode PK
Curr Oncol Rep; 2015 Dec; 17(12):54. PubMed ID: 26449842
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
Nonomura N; Oka D; Nishimura K; Nakayama M; Inoue H; Mizutani Y; Miki T; Okuyama A
Int J Urol; 2007 Jun; 14(6):527-31. PubMed ID: 17593098
[TBL] [Abstract][Full Text] [Related]
12. Cis-platin combination chemotherapy for non-seminomatous germ-cell tumours of the testis.
Abratt RP; Pontin AR; Sarembock LA; Barnes RD; Livingstone RR
S Afr Med J; 1987 Oct; 72(7):468-9. PubMed ID: 2443988
[TBL] [Abstract][Full Text] [Related]
13. Investigational targeted therapies for the treatment of testicular germ cell tumors.
Oing C; Kollmannsberger C; Oechsle K; Bokemeyer C
Expert Opin Investig Drugs; 2016 Sep; 25(9):1033-43. PubMed ID: 27286362
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of chemotherapy for advanced testicular and extragonadal germ cell tumors: a single-center 27-year experience.
Tanaka T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T
Jpn J Clin Oncol; 2010 Jan; 40(1):73-8. PubMed ID: 19773268
[TBL] [Abstract][Full Text] [Related]
15. Acute respiratory distress syndrome in poor prognostic germ cell tumor with multiple lung metastases: a case report.
Naseer MA; Mohammed SS; Das Majumdar SK; Patnaik R; Al Tublani HM; Justin JS; Meddikar JA
Gulf J Oncolog; 2011 Jul; (10):69-71. PubMed ID: 21724533
[TBL] [Abstract][Full Text] [Related]
16. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
[TBL] [Abstract][Full Text] [Related]
17. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
[TBL] [Abstract][Full Text] [Related]
18. Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.
Korkola JE; Houldsworth J; Bosl GJ; Chaganti RS
BJU Int; 2009 Nov; 104(9 Pt B):1334-8. PubMed ID: 19840009
[TBL] [Abstract][Full Text] [Related]
19. Phase II clinical trial of oxaliplatin and bevacizumab in refractory germ cell tumors.
Jain A; Brames MJ; Vaughn DJ; Einhorn LH
Am J Clin Oncol; 2014 Oct; 37(5):450-3. PubMed ID: 23388561
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for good-risk germ cell tumors: current concepts and controversies.
Vaughn DJ
Urol Clin North Am; 2007 May; 34(2):171-7; abstract viii-ix. PubMed ID: 17484922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
